GlassScriptPhysician profile
Allen H Hord
NPI 1801845409
$9,272.96
in general payments reported to CMS, 2019-2025
52 companies · $1,334 in 2025
The $1,334 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,848 · 2020: $1,547 · 2021: $1,357 · 2022: $1,557 · 2023: $693 · 2024: $937 · 2025: $1,334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,963.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,762.61 | 2019-2023 | Senza |
| Boston Scientific Corporation | $944.00 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Forte Bio-Pharma LLC | $938.48 | 2019-2025 | Prolate, Nalocet, Tanlor |
| Collegium Pharmaceutical, INC. | $648.61 | 2019-2025 | Xtampza, Belbuca |
| Abbott Laboratories | $592.23 | 2020-2023 | Proclaim |
| Medtronic, INC. | $482.34 | 2022-2025 | Intellis Adaptivestim, Synchromedii |
| Medtronic USA, INC. | $391.75 | 2019-2020 | |
| Biotronik Nro, INC. | $254.18 | 2023-2025 | Biotronik, Prospera |
| Pacira Therapeutics, INC. | $192.38 | 2019-2020 | |
| Stryker Corporation | $172.01 | 2024 | Mild Device Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $167.26 | 2019-2025 | Relistor |
| Amgen INC. | $167.11 | 2019-2024 | Prolia, Evenity |
| Abbvie INC. | $162.94 | 2024-2025 | |
| Relievant Medsystems, INC. | $130.66 | 2021 | |
| Mdd US Operations, LLC | $124.54 | 2019-2020 |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Hord listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.